For 40 years now, Bedfont® has specialized in the design and manufacture of exhaled breath and gas monitoring instruments.
Regarded as pioneers in the breath analysis market, their products are now available in over 70 countries across the world. Breath analysis is the new blood test.
With several product ranges of breath analyzers for a range of different applications including:
- the Smokerlyzer® range, a motivational tool that has helped people to stop smoking for over 30 years
- the Gastrolyzer® range, which offers a non-invasive method, to diagnose food intolerances and gastrointestinal disorders
- the NObreath® FeNO monitor, a product which measures nitric oxide gas on the exhaled breath, helping to manage asthma and differentiate between other respiratory diseases
Bedfont® continues to develop and expand their product ranges to meet the demands of the market which is greatly expanding for their breath analysis products
About Bedfont Scientific Ltd.
Bedfont's wide range of breath analysis products can now be found in over 76 healthcare markets worldwide. they have a large presence overseas, and have achieved their international reputation for high quality products and services by carefully selecting their distributors.
Though their network of distributors, they're able to raise their brand awareness and keep up to date with market changes in the healthcare sector worldwide. One way in which they respond to their customer's needs is through their dedicated sales team.
Each member of their multi-lingual sales team is responsible for different geographical regions.
Through this structure they can concentrate on the demands of their customers and adapt to cultural and country specific needs, while increasing their company's profile in both the UK and overseas.
Bedfont® works in a specialist market and their products have been successfully commercialized worldwide for over 30 years. This is achieved by exhibiting at the most influential congresses, working with key opinion leaders and healthcare professionals.
A lot of their effort goes into post market surveillance to receive feedback about their products. End users can also engage with Bedfont® through their large social media presence.
Bedfont® always look for ways to help the community. they are key to cultivate growth through offering apprenticeships, which have been a successful scheme, in giving local students a chance to improve their business skills.
They also contribute to good causes through charity events, fundraisers, and coffee mornings, and commercially outsource materials and services to help other small companies throughout the UK.
As a company, they strive to reduce their carbon footprint. All of their consumer boards are recyclable and comply with the Waste Electrical and Electronic Equipment Recycling guidelines.
Bedfont® would not be able to provide the high levels of products or services that they do without their employees. Bedfont® is a family. Through team building and social events, they keep their employees happy and motivated.
A lot of the company's profits are invested back into Bedfont® for research and development for existing products and new products to save people's lives.
Bedfont's aim for the future is to continue with their scientific contributions to improve global health, one breath at a time.
About Bedfont Scientific
Bedfont® Scientific has specialised in the design and manufacture of exhaled breath and gas monitoring instruments since 1976.
For medical gas monitoring, their Medi-Gas Check medical pipeline testing range verifies not only the quantity but also quality of gas administered to patients.
Bedfont's breath analysers include carbon monoxide (CO) monitors such as the Smokerlyzer®, used for smoking cessation, and the ToxCO®, used by emergency services, to diagnose CO poisoning.
The NObreath® FeNO monitor provides accurate analysis of airway inflammation for the control of asthma, and the Gastrolyzer® range aids in the detection of gastrointestinal disorders and food intolerances. Quick and non-invasive, breath analysis is the new blood test.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.